bioRxiv ScienceSearch

Biology subjects

Hilger, D.

Publications and source records attributed to Hilger, D..

2 recordsLinked to original sources

Local membrane charge regulates β2 adrenergic receptor coupling to Gi

G protein coupled receptors (GPCRs) are transmembrane receptors that signal through heterotrimeric G proteins. Lipid modifications anchor G proteins to the plasma membrane; however, little is known about the effect of phospholipid composition on GPCR-G protein coupling. The {beta}2 adrenergic receptor ({beta}2AR) signals through both Gs and Gi in cardiac myocytes where studies suggest that Gi signaling may be cardioprotective. However, Gi coupling is much less efficient than Gs coupling in most cell-based and biochemical assays, making it difficult to study {beta}2AR-Gi interactions. To investigate the role of phospholipid composition on Gs and Gi coupling, we reconstituted {beta}2AR in detergent/lipid mixed micelles and found that negatively charged phospholipids (PS and PG) inhibit {beta}2AR-Gi3 coupling. Replacing negatively charged lipids with neutral lipids (PC or PE) facilitated the formation of a functional {beta}2AR-Gi3 interaction that activated Gi3. Ca2+, known to interact with negatively charged PS, facilitated {beta}2AR-Gi3 interaction in PS. Mutational analysis suggested that Ca2+ interacts with the negatively charged EDGE motif on the carboxyl-terminal end of the N helix of Gi3 and coordinates an EDGE-PS interaction. These results were confirmed in {beta}2AR reconstituted into nanodisc phospholipid bilayers. {beta}2AR-Gi3 interaction was favored in neutral lipids (PE and PC) over negatively charged lipids (PG and PS). In contrast, basal {beta}2AR-Gs interaction was favored in negatively charged lipids over neutral lipids. In negatively-charged lipids, Ca2+ and Mg2+ facilitated {beta}2AR-Gi3 interaction. Taken together, our observations suggest that local membrane charge modulates the interaction between {beta}2AR and competing G protein subtypes.

biochemistry

Platform for rapid nanobody discovery in vitro

Camelid single-domain antibody fragments (\"nanobodies\") provide the remarkable specificity of antibodies within a single immunoglobulin VHH domain. This unique feature enables applications ranging from their use as biochemical tools to therapeutic agents. Virtually all nanobodies reported to date have been obtained by animal immunization, a bottleneck restricting many applications of this technology. To solve this problem, we developed a fully in vitro platform for nanobody discovery based on yeast surface display of a synthetic nanobody scaffold. This platform provides a facile and cost-effective method for rapidly isolating nanobodies targeting a diverse range of antigens. We provide a blueprint for identifying nanobodies starting from both purified and non-purified antigens, and in addition, we demonstrate application of the platform to discover rare conformationally-selective nanobodies to a lipid flippase and a G protein-coupled receptor. To facilitate broad deployment of this platform, we have made the library and all associated protocols publicly available.

biochemistry